Kristin C. Peck - Nov 26, 2021 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role: Chief Executive Officer, Director
Signature: /s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol: ZTS
Transactions as of: Nov 26, 2021
Transactions value $: -$2,864,275
Form type: 4
Date filed: 11/29/2021, 03:46 PM
Previous filing: Oct 12, 2021
Next filing: Jan 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZTS	Common Stock	Options Exercise	$371K	+12K	+41.49%	$30.89^*	40.9K	Nov 26, 2021	Direct	F1
transaction	ZTS	Common Stock	Sale	-$133K	-600	-1.47%	$221.92	40.3K	Nov 26, 2021	Direct	F2
transaction	ZTS	Common Stock	Sale	-$1.76M	-7.9K	-19.59%	$222.37	32.4K	Nov 26, 2021	Direct	F3
transaction	ZTS	Common Stock	Sale	-$806K	-3.6K	-11.1%	$223.78	28.8K	Nov 26, 2021	Direct	F4
transaction	ZTS	Common Stock	Sale	-$494K	-2.2K	-7.63%	$224.72	26.6K	Nov 26, 2021	Direct	F5
transaction	ZTS	Common Stock	Sale	-$45.1K	-200	-0.75%	$225.44	26.4K	Nov 26, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZTS	Stock Option	Options Exercise	$0	-12K	-4.01%	$0.00	287K	Nov 26, 2021	Common Stock	12K		Direct	F6, F7, F8, F9, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.
F2	The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.26 to $222.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.27 to $223.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.27 to $224.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.36 to $225.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F7	12,000 options granted March 4, 2014 at an exercise price of $30.89 per option.
F8	Each option vests on the third anniversary of the date of grant.
F9	Each option expires on the tenth anniversary of the date of grant.
F10	15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; and 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option.